1. Academic Validation
  2. SRI-42127, a novel small molecule inhibitor of the RNA regulator HuR, potently attenuates glial activation in a model of lipopolysaccharide-induced neuroinflammation

SRI-42127, a novel small molecule inhibitor of the RNA regulator HuR, potently attenuates glial activation in a model of lipopolysaccharide-induced neuroinflammation

  • Glia. 2022 Jan;70(1):155-172. doi: 10.1002/glia.24094.
Rajeshwari Chellappan 1 2 Abhishek Guha 1 Ying Si 1 2 Thaddaeus Kwan 1 Louis B Nabors 1 Natalia Filippova 1 Xiuhua Yang 1 Anish S Myneni 1 Shriya Meesala 1 Ashley S Harms 1 Peter H King 1 2 3
Affiliations

Affiliations

  • 1 Department of Neurology, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
  • 2 Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, USA.
  • 3 Department of Cell, Developmental, and Integrative Biology, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA.
Abstract

Glial activation with the production of pro-inflammatory mediators is a major driver of disease progression in neurological processes ranging from acute traumatic injury to chronic neurodegenerative diseases such as amyotrophic lateral sclerosis and Alzheimer's disease. Posttranscriptional regulation is a major gateway for glial activation as many mRNAs encoding pro-inflammatory mediators contain adenine- and uridine-rich elements (ARE) in the 3' untranslated region which govern their expression. We have previously shown that HuR, an RNA regulator that binds to AREs, plays a major positive role in regulating inflammatory cytokine production in glia. HuR is predominantly nuclear in localization but translocates to the cytoplasm to exert a positive regulatory effect on RNA stability and translational efficiency. Homodimerization of HuR is necessary for translocation and we have developed a small molecule inhibitor, SRI-42127, that blocks this process. Here we show that SRI-42127 suppressed HuR translocation in LPS-activated glia in vitro and in vivo and significantly attenuated the production of pro-inflammatory mediators including IL1β, IL-6, TNF-α, iNOS, CXCL1, and CCL2. Cytokines typically associated with anti-inflammatory effects including TGF-β1, IL-10, YM1, and Arg1 were either unaffected or minimally affected. SRI-42127 suppressed microglial activation in vivo and attenuated the recruitment/chemotaxis of neutrophils and monocytes. RNA kinetic studies and luciferase studies indicated that SRI-42127 has inhibitory effects both on mRNA stability and gene promoter activation. In summary, our findings underscore HuR's critical role in promoting glial activation and the potential for SRI-42127 and other HuR inhibitors for treating neurological diseases driven by this activation.

Keywords

HuR inhibitor; LPS; RNA binding protein; RNA regulation; neuroinflammation.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-148853
    99.64%, HuR Translocation Inhibitor
    HuR